Showing results 1 to 25 of 25
|A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
|Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities.
|Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin
|Autophagy mechanisms in sputum and peripheral blood cells of patients with severe asthma: a new therapeutic target
|박해심, 반가영, 신유섭, 예영민, 최용준
|BCL2 Interacting Protein 3-like/NIX-mediated Mitophagy Plays an Important Role in the Process of Age-related Hearing Loss
|김연주, 우현구, 장정훈, 정연훈
|Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
|Cigarette smoke condensate may disturb immune function with apoptotic cell death by impairing function of organelles in alveolar macrophages
|Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
|Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
|Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
|Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
|강호철, 백은주, 우현구, 이수환, 최용준
|Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors.
|Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker.
|Ionizing radiation can overcome resistance to TRAIL in TRAIL-resistant cancer cells.
|Low-intensity ultrasound inhibits apoptosis and enhances viability of human mesenchymal stem cells in three-dimensional alginate culture during chondrogenic differentiation.
|Mitochondrial dysfunction suppresses p53 expression via calcium-mediated nuclear factor-kB signaling in HCT116 human colorectal carcinoma cells
|NLRP1 and NTN1, Deregulated Blood Differentially Methylated Regions in Mild Cognitive Impairment Patients
|Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation.
|OTUB1 knockdown promotes apoptosis in melanoma cells by upregulating TRAIL expression
|Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells.
|Regulation of singlet oxygen-induced apoptosis by cytosolic NADP+-dependent isocitrate dehydrogenase.
|Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
|Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
|Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5.
|The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells